T. Rowe Price Associates
VASC

T. Rowe Price Associates’s Vascular Solutions Inc VASC Stock Holding History

T. Rowe Price Associates’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-231,780
Closed -$11.2M – 2582
2016
Q3 		$11.2M Sell
231,780
-2,240
-1% -$104K ﹤0.01% 1291
2016
Q2 		$9.75M Buy
+234,020
New +$8.71M ﹤0.01% 1300

Other funds holding VASC

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

T. Rowe Price Associates's VASC Position: Q4 2016 in Review

T. Rowe Price Associates sold out of Vascular Solutions Inc (VASC) in Q4 2016, closing a stake of 231,780 shares — an estimated $11.2M sold.

T. Rowe Price Associates first reported a position in VASC in Q2 2016 and held it in 2 quarters. The position peaked at $11.2M in Q3 2016. 163 funds tracked by Wall St. Rank hold VASC as of Q4 2016.

  • T. Rowe Price Associates reported no remaining Vascular Solutions Inc position as of Q4 2016 after selling out during the quarter.
  • T. Rowe Price Associates sold 231,780 Vascular Solutions Inc shares in Q4 2016, an estimated $11.2M.
  • T. Rowe Price Associates first reported a position in Vascular Solutions Inc in Q2 2016 and held it in 2 quarters.
  • T. Rowe Price Associates's Vascular Solutions Inc position peaked at $11.2M in Q3 2016.
  • 163 funds tracked by Wall St. Rank held Vascular Solutions Inc as of Q4 2016.

Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.